Rhabdomyosarcome paratesticulaire

Radouane, B.; Fenni, J. El; Chaouir, S.; Amil, T.; Hanine, A.; Ameur, M. Ben

doi:10.1016/s0221-0363(04)97683-4

Cited by 5 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The tumor appears homogeneous in T1-weighted images and heterogeneous in T2-weighted images with signal intensity similar to that in a normal testis. The low signal intensity of the tunica albuginea in T2-wieghted images allows the visualization of a clear separation of the mass from the testis [1,5,6]. …”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Embryonic paratesticular rhabdomyosarcoma: a case report

Bouchikhi¹,

Mellas²,

Tazi³

et al. 2013

J Med Case Reports

View full text Add to dashboard Cite

IntroductionAn embryonic paratesticular rhabdomyosarcoma is a very rare mesenchymal tumor. It is an intrascrotal tumor that is localized in paratesticular structures such as the epididymis or spermatic cord. Rhabdomyosarcoma is most often observed in children and adolescents, presenting as a painless scrotal mass.Case presentationOur patient was an 18-year-old Moroccan man who presented with a painless left scrotal mass that had evolved over four months. An inguinal orchiectomy was performed. A histological examination of the excised tissue revealed an embryonic rhabdomyosarcoma.Our patient had three sessions of chemotherapy with vincristine, actinomycin C and cyclophosphamide. Each chemotherapy session was conducted over five days, with a cycle of 21 days. Our patient was assessed two months after the last chemotherapy session and demonstrated good clinical improvement.ConclusionParatesticular rhabdomyosarcoma is a rare aggressive tumor manifesting in children and very young adults. Localized forms have a good prognosis whereas metastatic tumors show very poor results. A well-defined treatment based on surgery and chemotherapy yields good results.

show abstract

Section: Discussionmentioning

confidence: 99%

“…It is an intrascrotal tumor that is localized in paratesticular structures such as the epididymis or spermatic cord. Rhabdomyosarcoma is most often observed in children and adolescents where it is usually presents as a painless scrotal mass [1]. …”

Section: Introductionmentioning

confidence: 99%

Embryonic paratesticular rhabdomyosarcoma: a case report

Bouchikhi¹,

Mellas²,

Tazi³

et al. 2013

J Med Case Reports

View full text Add to dashboard Cite

show abstract

“…They are aggressive tumors especially in children. It requires early diagnosis, accurate clinical and radiological extension assessment and well-codified treatment based on the pathological stage [1]. Paratesticular rhabdomyosarcomas typically present as a unilateral, painless scrotal swelling or mass.…”

Section: Introductionmentioning

confidence: 99%

Case Report: The Paratesticular Rhabdomyosarcoma in Children

Azizi¹,

Babakhouya²,

Rkain³

et al. 2021

JCT

View full text Add to dashboard Cite

Rhabdomyosarcoma is a rare and aggressive mesenchymal tumor, whose paratesticular location is the most common genitourinary site. It is the prerogative of the child and the young adult. On physical examination, a painless scrotal tumefaction is observed. His diagnosis is essentially provided by testicular ultrasound. His therapeutic strategy is codified and based on the combination of chemotherapy and surgical excision or radiotherapy. The precocity of the management and the accuracy of the extension and radiology tests are important for the vital and functional prognosis. We report a case of paratesticular rhabdomysarcoma of alveolar type, diagnosed in front of a large left painless scrotal mass, which has been evolving for less than one month in a 7-year-old child. An inguinal orchiectomy was performed. A histological examination of the excised tissue revealed an epididymal RMS of the alveolar type. Our patient had 9 chemotherapy sessions with vincristine, actinomycin C and cyclophosphamide. Each chemotherapy session took place over four days, with a 21-day cycle. He was evaluated for 4 years and demonstrated good clinical improvement. The experience gained from the index case is crucial for the management of patients with intratesticular rhabdomyosarcoma who must always ensure that the radical inguinal orchiectomy with lymph node dissection is covered by chemotherapy and/or radiotherapy. This will potentially reduce the chances of tumor recurrence and/or metastasis, thus improving patient prognosis.

show abstract